Applied Genetic Technologies
Latest round
- Series B
Last raised
- Apr 2013
Total raised
- $54M
Investors
- 7
About Applied Genetic Technologies
Applied Genetic Technologies Corp.Founded in 1999 and headquartered in Alachua, US, Applied Genetic Technologies Corp. specializes in gene therapy solutions. The company has undergone various strategic initiatives to advance its research in ocular conditions. Mohammed Abdulghani is one of the founders, while Sue Washer serves as the CEO.Applied Genetic Technologies Corp. focuses on developing gene therapies for retinal diseases, primarily targeting X-Linked Retinitis Pigmentosa (XLRP), Dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD). Its gene therapies aim to restore vision by enabling patients to produce essential proteins through modified cells.In 2022, Applied Genetic Technologies Corp. reported revenue of USD 325,000 and an EBITDA of USD -63,970,000. aims to further develop its therapies and explore additional treatments for eye diseases. The company also intends to expand its market presence globally, targeting specific markets in North America, Europe, and Asia by 2024.
Who invested in Applied Genetic Technologies
7 investors across 5 rounds
See all investors in Applied Genetic Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Applied Genetic Technologies
Who invested in Applied Genetic Technologies?
Applied Genetic Technologies has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Applied Genetic Technologies raised?
Applied Genetic Technologies has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Applied Genetic Technologies last raise money?
Applied Genetic Technologies's most recent round on record is a Series B, in Apr 2013.
What does Applied Genetic Technologies do?
Applied Genetic Technologies Corp.
Where is Applied Genetic Technologies headquartered?
Applied Genetic Technologies is headquartered in Alachua, US.
Which VCs invest in companies like Applied Genetic Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Applied Genetic Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Applied Genetic Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.